152 related articles for article (PubMed ID: 9747643)
1. Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus.
Pelikánová T; Pinsker P; Smrcková I; Stribrná L; Dryáková M
J Diabetes Complications; 1998; 12(5):264-72. PubMed ID: 9747643
[TBL] [Abstract][Full Text] [Related]
2. [Renal hemodynamics and its regulation in recently diagnosed type 1 diabetes mellitus (insulin-dependent diabetes mellitus). The effect of hyperglycemia].
Pelikánová T; Pinsker P; Smrcková I; Stríbrná L; Dryáková M
Cas Lek Cesk; 1997 Sep; 136(17):533-8. PubMed ID: 9441014
[TBL] [Abstract][Full Text] [Related]
3. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control.
Mayfield RK; Margolius HS; Levine JH; Wohltmann HJ; Loadholt CB; Colwell JA
J Clin Endocrinol Metab; 1984 Aug; 59(2):278-86. PubMed ID: 6564131
[TBL] [Abstract][Full Text] [Related]
4. Effects of insulin and lipid emulsion on renal haemodynamics and renal sodium handling in IDDM patients.
Pelikánová T; Smrcková I; Krízová J; Stríbrná J; Lánská V
Diabetologia; 1996 Sep; 39(9):1074-82. PubMed ID: 8877292
[TBL] [Abstract][Full Text] [Related]
5. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
6. Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins.
Esmatjes E; Fernandez MR; Halperin I; Camps J; Gaya J; Arroyo V; Rivera F; Figuerola D
J Clin Endocrinol Metab; 1985 Jun; 60(6):1231-6. PubMed ID: 3858281
[TBL] [Abstract][Full Text] [Related]
7. Effect of acute hyperglycaemia on sodium handling and excretion of nitric oxide metabolites, bradykinin, and cGMP in Type 1 diabetes mellitus.
Simková R; Kazdová L; Karasová L; Simek S; Pelikánová T
Diabet Med; 2004 Sep; 21(9):968-75. PubMed ID: 15317600
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of natriuresis in diabetic nephropathy].
Późniak J
Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
[TBL] [Abstract][Full Text] [Related]
9. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
[TBL] [Abstract][Full Text] [Related]
10. Plasma renin activity and urinary kallikrein excretion in response to intravenous furosemide in diabetic patients.
Lall SB; Kunchaparty S; Siddiqui HH; Bajaj JS
Acta Diabetol Lat; 1990; 27(4):337-42. PubMed ID: 2087934
[TBL] [Abstract][Full Text] [Related]
11. The two mechanisms involved in the control of urinary kallikrein excretion.
Mills IH; Newport PA
Adv Exp Med Biol; 1986; 198 Pt B():233-41. PubMed ID: 3643725
[TBL] [Abstract][Full Text] [Related]
12. Urinary kallikrein excretion in type 1 (insulin-dependent) diabetes mellitus.
Manto A; Cotroneo P; Porcelli G; D'Errico G; Marra G; Magnani P; Tilli P; Greco AV; Ghirlanda G
Diabetologia; 1993 May; 36(5):423-7. PubMed ID: 8314446
[TBL] [Abstract][Full Text] [Related]
13. Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems.
Overlack A; Stumpe KO; Müller HM; Kolloch R; Higuchi M
Klin Wochenschr; 1982 Oct; 60(19):1223-8. PubMed ID: 6183482
[TBL] [Abstract][Full Text] [Related]
14. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
[TBL] [Abstract][Full Text] [Related]
15. Relationship of urinary kallikrein excretion to urinary potassium excretion during furosemide administration with and without amiloride.
Obika LF
Arch Int Physiol Biochim; 1987 Mar; 95(1):13-8. PubMed ID: 2441670
[TBL] [Abstract][Full Text] [Related]
16. Relationship between kallikrein and PRA after intravenous furosemide.
Cinotti GA; Stirati G; Taggi F; Ronci R; Simonetti BM; Pierucci A
J Endocrinol Invest; 1979; 2(2):147-50. PubMed ID: 489923
[TBL] [Abstract][Full Text] [Related]
17. Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function.
Harvey JN; Edmundson AW; Jaffa AA; Martin LL; Mayfield RK
Diabetologia; 1992 Sep; 35(9):857-62. PubMed ID: 1397781
[TBL] [Abstract][Full Text] [Related]
18. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
19. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
[TBL] [Abstract][Full Text] [Related]
20. Hypertension in adult onset diabetes mellitus: abnormal renal hemodynamics and endogenous vasoregulatory factors.
Olshan AR; O'Connor DT; Cohen IM; Stone RA
Am J Kidney Dis; 1982 Sep; 2(2):271-80. PubMed ID: 6751073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
